ANIP - ANI Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue128,62276,32255,970
Cost of Revenue48,78012,69211,473
Gross Profit79,84263,63044,497
Operating Expenses
Research Development2,9062,8742,678
Selling General and Administrative27,82921,15617,935
Non Recurring6,6856,6856,685
Total Operating Expenses59,763--
Operating Income or Loss20,07932,70020,006
Income from Continuing Operations
Total Other Income/Expenses Net-7441160
Earnings Before Interest and Taxes20,00532,74120,166
Interest Expense11,32711,008787
Income Before Tax8,67821,73319,379
Income Tax Expense4,7446,358-9,368
Minority Interest---
Net Income From Continuing Ops3,93415,37528,747
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income3,93415,37528,747
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares3,93415,37528,747